due
weak
immunogen
convent
vaccin
especi
subunit
vaccin
alway
combin
adjuv
ensur
potent
immun
respons
polyethylenimin
pei
kind
cation
polym
extens
appli
nucleotid
deliveri
reagent
decad
recent
year
robust
adjuvant
pei
continu
document
increas
evid
shown
peibas
particl
capabl
improv
effici
convent
vaccin
infect
tumor
effici
character
direct
indic
enhanc
matur
rate
antigenpres
cell
apc
increas
prolifer
effector
cell
well
amplifi
product
antigenspecif
antibodi
variou
cytokin
chemokin
review
first
introduc
physicochem
properti
pei
gener
applic
distinct
area
focu
effect
neat
pei
peibas
nanoparticlesmicroparticl
npsmp
antigen
uptak
present
foundat
understand
interplay
pei
apc
extend
focu
effect
peirelev
adjuv
potenc
cell
level
preclin
studi
clinic
trial
subsequ
fascin
figur
possibl
underli
mechan
intrins
immunoactiv
function
final
discuss
challeng
futur
perspect
applic
pei
vaccin
explor
promis
approach
optim
immun
respons
manipul
toxic
properli
np
success
transfer
dna
nerv
stem
cell
subsequ
pei
drawn
attent
biomed
field
especi
drug
carrier
biolog
label
vaccin
adjuv
tabl
among
deliv
drug
common
one
nucleic
acid
pei
second
accept
nonvir
nucleic
acid
transfer
agent
besid
polyllysin
pll
nowaday
pei
transfect
reagent
commerci
avail
includ
jetpei
besid
nucleic
acid
protein
peptid
also
includ
categori
pei
also
work
biolog
label
conjug
imag
agent
fe
fluoresc
np
reflect
specif
cell
subcel
inform
migrat
behavior
certain
condit
adjuv
effect
pei
emerg
area
seri
recent
studi
vaccin
compos
pei
immunostimul
quit
compet
treat
infect
tumor
better
manipul
adjuvant
strategi
construct
peibas
vaccin
highli
desir
pei
could
incorpor
vaccin
structur
differ
way
directli
bind
antigen
coat
antigenload
npsmp
coat
exist
particl
antigen
absorb
surfac
coencapsul
npsmp
antigen
construct
form
figur
process
plenti
cytokin
ligand
could
also
ad
vaccin
base
desir
applic
first
step
vaccin
take
effect
endocytosi
process
apc
similar
tradit
vaccin
factor
influenc
cell
uptak
peibas
vaccin
includ
size
shape
charg
surfac
chemistri
particl
intern
journal
nanomedicin
submit
manuscript
wwwdovepresscom
broad
rang
molecular
weight
differ
topolog
plenti
modif
possibl
peibas
polyplex
rather
versatil
size
shape
properti
therefor
peibas
vaccin
demonstr
broad
possibl
applic
also
strong
posit
charg
pei
benefici
cellular
intern
pei
bind
neg
proteoglycan
cell
membran
mediat
uptak
process
electrostat
interact
gener
phagocytosi
immun
cell
foreign
particl
actindepend
process
loos
organ
pei
neat
state
disturb
actin
remodel
initi
intern
yet
pei
compress
neg
substanc
condens
small
particl
peicoat
strategi
result
smooth
surfac
spheric
particl
symmetr
easili
uptaken
point
attach
size
one
use
factor
toolbox
affect
uptak
peibas
particl
well
polymer
particul
carrier
champion
et
al
demonstr
particl
size
play
role
phagocytosi
volum
larger
cell
size
rel
easi
achiev
smallsiz
peibas
polym
peicoat
larg
mp
uptak
process
restrict
howev
electrostat
forc
attach
huge
particl
cell
membran
perform
continu
depot
antigen
effect
surfac
properti
peibas
polyplex
cellular
uptak
addit
gener
paramet
signific
attent
paid
chemic
modif
surfac
chemistri
modif
would
larg
influenc
cellular
uptak
peibas
polyplex
apc
phagocytosi
frequent
mediat
receptor
via
mannos
receptor
complement
receptor
receptorand
scaveng
receptormedi
pathway
pathway
target
modif
obvious
improv
cellular
uptak
effici
subsequ
biolog
effect
polyplex
mp
less
posit
charg
particl
tether
target
moieti
particl
surfac
even
import
endocytosi
hu
et
al
prepar
mannosemodifi
peicellpenetr
peptid
cpp
dna
particl
found
improv
effici
worth
note
tolllik
receptor
tlr
includ
phagocytosisrel
receptor
initi
phagosomemedi
apc
matur
inflammatori
secret
discuss
review
cho
et
al
report
maltosyl
peimedi
vaccin
cervic
cancer
effect
neat
human
papillomaviru
antigen
presum
receptormedi
endocytosi
peibas
particl
maltos
subsequ
enhanc
transfect
effici
peicoat
npsmp
similar
pattern
receptormedi
gene
deliveri
also
demonstr
mesopor
silica
np
coupl
pei
also
demonstr
high
transfect
effici
due
effect
target
apc
besid
specif
receptormedi
target
strategi
anoth
nonspecif
target
method
hydrophob
modif
pei
given
lipophil
natur
cell
membran
lipidlik
structur
facilit
interact
hydrophob
speci
plasma
membran
eg
lysosom
membran
nuclear
membran
demonstr
acetyl
branch
pei
bpei
enhanc
cellular
uptak
abil
fourfold
correspond
hydrophob
interact
theori
lipid
compon
incorpor
though
possess
rel
decreas
posit
charg
electrostat
interact
could
still
maintain
aid
bind
recent
parhiz
et
al
report
hexanoatedpei
vector
also
effect
correspond
nonhydrophob
pei
enhanc
transfect
rate
besid
transfect
benefit
wang
et
al
prove
hydrophob
modif
alkyl
chain
pei
vaccin
optim
crosspresent
antigen
upregul
secret
yet
correl
polyethyleniminebas
micronanoparticl
adjuv
properti
synthes
hydrophobicmodifi
pei
vaccin
potenc
still
need
investig
cpp
anoth
valuabl
speci
optim
interact
cell
membran
peibas
polyplex
cpp
character
polycation
amino
acid
residu
ie
arginin
lysin
known
special
abil
penetr
cellular
membran
studi
demonstr
cpp
take
effect
electrostat
bind
neg
charg
cell
membran
induct
vesicl
ruptur
osmot
chang
andor
membran
lysi
truncat
tat
peptid
penetratin
popular
cpp
argininerich
peptid
recent
morri
sharma
construct
argininemodifi
oligo
alkylaminosiloxan
graft
pei
found
modifi
peipdna
exhibit
cell
viabil
gene
transfect
effici
neat
bpei
human
nasopharyng
epidermoid
carcinoma
inhibitor
studi
use
variou
cellular
uptak
inhibitor
wortmannin
genistein
indic
role
arginin
moieti
promot
intern
polyplex
process
possibl
contain
combin
multipl
pathway
modif
strategi
develop
magnifi
advantag
peibas
vaccin
initi
process
yet
certain
modif
particl
size
charg
paramet
polym
may
vari
correspondingli
though
area
studi
separ
interplay
among
paramet
must
consid
whole
identifi
best
perform
boost
uptak
uptaken
antigen
process
transport
differ
cell
compart
final
present
within
peptidebind
groov
major
histocompat
complex
mhc
molecul
mhc
class
molecul
class
ii
molecul
cell
receptor
recogn
antigen
present
pattern
mostli
mhc
class
molecul
present
endogen
peptid
transform
infect
cell
compon
elicit
cellmedi
immun
cmi
class
ii
molecul
acquir
exogen
peptid
extracellular
pathogen
vaccin
peptid
induc
abund
antibodi
peibas
vaccin
antigen
peptid
mainli
follow
exogenousclass
ii
pathway
stimul
humor
immun
peibas
dna
vaccin
provid
opportun
synthes
multipl
antigen
apc
stimul
effect
cellular
immun
longlast
memori
immun
howev
dna
actual
deliv
bystand
cell
myocyt
fibroblast
case
newli
synthes
antigen
peptid
present
secret
bystand
cell
shuttl
apc
act
exogen
antigen
proton
spong
effect
pei
make
crosspresent
possibl
mention
mhc
class
molecul
present
endogen
peptid
synthes
cell
class
ii
molecul
present
exogen
intern
antigen
occasion
mhc
class
molecul
also
particip
present
exogen
antigen
known
crosspresent
meaning
biolog
evolut
human
be
sinc
viru
invas
commonli
occur
profession
apc
cmi
natur
gener
viru
antigen
releas
bystand
cell
turn
exogen
antigen
apc
crosspresent
mechan
apc
larg
increas
effici
immun
system
gener
cmi
elimin
infect
cell
yet
applic
vaccin
treat
cancer
infect
need
cmi
instead
mere
humor
immun
crosspresent
also
great
import
process
phagocytos
endocytos
antigen
escap
vacuol
gain
entri
cytosol
known
lysosom
escap
becom
qualifi
client
ubiquitin
subsequ
degrad
proteasom
follow
transport
associ
antigen
process
tap
mediat
transfer
endoplasm
reticulum
present
mhc
class
molecul
two
repres
mechan
lysosom
escap
variat
osmot
pressur
membran
lytic
activ
phsensit
biomateri
possess
membranedestabil
properti
thu
good
candid
pei
uniqu
proton
spong
effect
buffer
acid
condit
involv
acid
condit
atpmedi
phdepend
proton
pump
open
follow
passiv
influx
chlorid
ion
water
molecul
result
hyperosmolar
state
instantan
caus
vesicl
burst
lysosom
escap
process
peibas
polyplex
well
record
merdan
et
al
figur
pei
ribozym
pllribozym
migrat
live
cell
identifi
confoc
laser
scan
microscop
found
first
gather
acid
vesicl
intern
journal
nanomedicin
submit
manuscript
wwwdovepresscom
shen
et
al
probabl
lysosom
unlik
pllbase
complex
vesicl
contain
peibas
complex
met
sudden
burst
let
content
throughout
cytoplasm
verifi
function
ph
chang
lysosom
escap
process
pei
prepar
pei
ribozym
group
bafilomycin
select
inhibitor
endosomallysosom
acidif
show
lysosom
ruptur
suggest
major
role
acidif
procedur
escap
antigen
peptid
dna
peibas
vaccin
cytoplasm
prepar
undergo
crosspresent
process
process
recent
verifi
song
et
al
found
peicoat
poli
lactidecoglycolid
plga
ova
np
induc
effici
crosspresent
antigen
mhc
class
molecul
endosom
escap
lysosom
process
group
membranedestabil
peptid
shown
possibl
promot
cell
uptak
also
improv
lysosom
escap
even
nuclear
transloc
although
pei
proton
spong
effect
carri
lysosom
escap
sometim
incompet
addit
membranedestabil
peptid
cpp
vaccin
improv
crosspresent
effect
ogri
et
al
explain
condit
studi
transfect
effici
cell
cell
cell
lower
small
peidna
particl
compar
larg
one
introduct
lysosomotrop
drug
chloroquin
phspecif
membraneact
peptid
realli
promot
substanti
increas
antigen
gene
express
confirm
hypothesi
import
ad
cpp
moieti
tan
et
al
bound
two
truncat
peptid
penetr
properti
bpei
result
higher
transfect
effici
without
caus
cytotox
cell
line
result
ascrib
enhanc
endosom
disrupt
activ
cppbound
pei
carrier
parent
carrier
peidna
vaccin
pei
help
nucleic
acid
protect
endosom
escap
yet
transfect
effici
may
still
limit
vaccin
particl
nm
diamet
kda
molecular
weight
requir
activ
aid
coupl
nuclear
local
signal
nl
nuclear
transloc
nl
peptid
usual
short
conserv
sequenc
bind
cytoplasm
importin
dock
nuclear
pore
complex
thu
aid
nucleic
acid
transcript
commonli
use
nl
contain
pkkkrkv
sequenc
addit
wellknown
argininerich
peptid
tat
penetratin
also
possess
nuclear
transport
activ
besid
mani
viralorigin
peptid
even
histon
protamin
ribonucleoprotein
highmotilitygroup
protein
other
contain
polycation
amino
acid
also
act
effect
nl
parhiz
et
al
investig
effici
peidna
vaccin
attach
differ
argininerich
sequenc
found
argininerich
deriv
pei
induc
higher
dna
sirna
transfect
effici
polyethyleniminebas
micronanoparticl
adjuv
group
without
modif
moreov
peidna
vaccin
conjug
argininerich
peptid
hydrophob
deriv
demonstr
highest
dna
transfect
effici
indic
ration
design
two
modif
promis
get
better
transfect
effici
antigen
dna
express
lower
cytotox
effort
elev
dna
transfect
promis
antigen
dna
translat
present
advantag
modif
strategi
peibas
vaccin
relat
antigen
uptak
present
illustr
figur
assess
perform
peibas
vaccin
must
consid
follow
three
level
vitro
vivo
clinic
trial
clearli
clinic
trial
larg
sampl
convinc
data
evalu
effici
newli
develop
vaccin
although
got
much
data
anim
trial
support
superior
effect
peibas
vaccin
trial
peibas
vaccin
process
clinic
level
summar
applic
peibas
vaccin
anim
experi
infect
cancer
tabl
respect
vivo
applic
vaccin
confront
bottleneck
sometim
two
main
reason
one
safeti
issu
pei
wide
known
toxic
complic
microenviron
vivo
microenviron
everi
immuneact
materi
correspond
target
immun
cell
cell
secret
variou
chemokin
attract
monocyt
granulocyt
immunepromot
cell
attract
cell
secret
cytokin
form
posit
feedback
frequent
depict
mani
tradit
adjuv
monocyt
ultim
uptak
complex
differenti
dendrit
cell
dc
phagocyt
migrat
secondari
lymphoid
tissu
intriguingli
pei
local
inflamm
seem
benefici
recruit
activ
apc
though
gener
process
somewhat
clear
detail
signal
commun
one
specif
vaccin
vivo
applic
still
puzzl
exampl
found
intramuscularli
inject
aluminum
adjuv
target
differ
cell
type
recruit
cell
similar
potenti
engulf
carrierantigen
complex
event
occur
drain
lymph
node
dln
certain
time
interv
probabl
due
bystand
effect
research
indic
differ
lipopolysaccharid
lp
aluminum
took
tlrindepend
mechan
activ
immun
bia
monocyt
differenti
dc
rather
macrophag
yet
peibas
vaccin
sever
issu
local
activ
cell
role
peibas
vaccin
secret
cytokin
uptak
differenti
process
along
lymph
drainag
situat
need
investig
illustr
show
uptak
present
process
peibas
vaccin
modifi
form
posit
charg
round
shape
control
size
peibas
mp
np
benefit
contribut
uptak
process
besid
could
modifi
prr
ligand
hydrophob
moieti
cpp
facilit
polyplex
intern
receptormedi
rout
membran
fusion
penetr
process
unknown
rout
polyplex
degrad
endosom
lysosom
releas
antigen
present
onto
mhc
molecul
directli
transmiss
indirectli
gene
express
process
pei
lysosom
escap
featur
vaccin
cppsmodifi
pei
possess
potent
lysosom
escap
properti
assist
crosspresent
deliv
antigen
nl
special
sequenc
ad
nucleic
acid
assist
nuclear
transloc
polym
polyethyleniminebas
micronanoparticl
adjuv
other
peibas
vaccin
work
almost
known
immun
rout
usual
mimic
pathogenesi
diseas
exampl
respiratori
infect
intranas
administr
prone
elicit
mucos
secretori
antibodi
well
serum
antibodi
similar
trend
found
hiv
vaccin
elicit
antibodi
vagina
detect
marker
prove
efficaci
vaccin
usual
two
main
aspect
intermedi
indic
antigen
dna
express
apc
matur
rate
humor
cellular
immun
respons
serum
lymphoid
organ
tissu
helper
type
helper
type
respons
bia
memori
b
cell
product
secret
level
relat
cytokin
comprehens
effect
higher
anim
surviv
rate
less
weight
loss
less
tumor
metastasi
rate
vaccin
demonstr
posit
result
seri
vivo
experi
clinic
trial
perform
satisfactori
exampl
dermavir
mannosylatedpeiplasmid
simian
hiv
dna
lisziewicz
et
al
perform
ex
vivo
dcbase
vaccin
dermavir
found
dermavirtransduc
autolog
monocytederiv
dc
induc
hivspecif
cell
rhesu
macaqu
moreov
group
improv
function
ex
vivo
dc
vaccin
strategi
topic
administr
compar
previou
ex
vivo
dcbase
vaccin
vaccin
strategi
propos
lisziewicz
et
al
result
similar
number
transduc
dc
lymph
node
induc
similar
quantiti
qualiti
hivspecif
cell
respons
dermavir
patch
test
phase
iii
clinic
trial
present
new
promis
agent
clinic
applic
though
mani
studi
show
perform
peibas
vaccin
vitro
vivo
immuneactiv
properti
pei
still
need
revisit
clear
studi
whether
improv
immun
effici
sole
due
antigen
protect
vaccin
deliveri
vehicl
due
intrins
adjuv
properti
immunostimul
pei
moreov
case
peicoat
polyplex
pei
togeth
npsmp
regard
whole
take
effect
encapsul
insid
even
difficult
prove
adjuvant
pei
thu
observ
immunoactiv
effect
pei
need
confirm
revel
possibl
molecular
pathway
peibas
vaccin
would
help
us
understand
develop
new
peibas
vaccin
notabl
biomateri
regard
wellknown
immunostimul
immunolog
activ
materi
continu
discov
underli
mechan
partial
explain
among
clinic
approv
adjuv
aluminum
good
exampl
besid
poli
acid
np
prove
activ
dc
pathway
similar
np
activ
polyanhydrid
np
fulleren
np
mediat
multipl
tlr
dc
inspir
vitro
vivo
result
also
suggest
immunoactiv
function
pei
especi
dna
vaccin
understand
abovest
characterist
pei
peibas
polyplex
necessari
provid
overview
adjuv
properti
underli
mechan
wellestablish
mode
adjuv
take
effect
direct
activ
apc
result
costimulatori
molecul
express
cytokin
secret
vitro
compar
bare
au
nanorod
aunr
peicoat
aunr
induc
higher
level
phenotyp
matur
dc
figur
cytokin
releas
immunepromot
effect
almost
match
lp
extent
subsequ
activ
specif
immun
interferon
ifn
product
strictli
envdepend
similarli
conjug
hepat
b
surfac
antigen
hbsag
cation
chitosan
peicoat
poli
lactic
acid
pla
mp
also
stronger
capabl
pla
mp
bare
antigen
promot
macrophag
intern
matur
follow
stronger
humor
immun
respons
vivo
antib
cell
lymphoma
vaccin
made
bpei
lpeifunction
plga
mp
also
result
higher
mhc
ii
express
cell
vitro
bare
mp
moreov
immunoactiv
effect
pei
also
assess
understand
better
vivo
effect
achiev
without
ad
pei
polyplex
compar
control
group
reveal
immunoactiv
properti
pei
gene
express
profil
vivo
immun
mice
pei
investig
compar
control
group
immunorel
gene
two
inject
group
activ
consider
high
level
regardless
antigen
figur
base
result
relat
analyz
pubgen
et
al
specul
pei
import
immuneactiv
effect
presum
granulocyt
colonystimul
factor
next
step
explor
interplay
mani
immunerel
gene
upregul
treatment
pei
interest
reveal
precis
molecular
pathway
behind
upregul
tlr
downstream
myeloid
differenti
primari
respons
gene
tirdomaincontain
adapterinduc
trif
pathway
classic
immunoactiv
rout
stimul
nuclear
transcript
factor
nuclear
activ
express
seri
cytokin
matur
marker
molecul
shokouhi
et
al
studi
seri
biomateri
found
mani
modul
matur
cytokin
secret
dc
differ
extent
vitro
tlr
cascad
effect
may
play
import
role
sens
exist
materi
hydrophob
domain
may
danger
signal
start
apc
activ
similar
pattern
antigen
huang
et
al
chen
et
al
found
cation
polym
cation
dextran
pei
promot
matur
macrophag
via
secret
typei
cytokin
figur
surprisingli
polyethyleniminebas
micronanoparticl
adjuv
especi
vivo
process
inflammasom
among
nodlik
receptor
nlr
kind
pattern
recognit
receptor
found
apc
inflammasom
known
activ
variou
stress
includ
k
efflux
reactiv
oxygen
speci
ro
gener
lysosom
ruptur
thu
inflammasom
activ
peiantigen
np
experi
potenti
lysosomaldestabil
activ
damageassoci
molecular
pattern
damp
caus
toxic
pei
interestingli
inflammasom
function
bias
adapt
immun
toward
respons
instead
affect
overal
pei
adjuv
activ
ro
ro
gener
alway
relat
tissu
cell
damag
kind
danger
signal
ro
innatemedi
proinflammatori
cytokin
tumor
necrosi
signal
arm
adapt
immun
suffici
demonstr
adjuv
effect
pei
mulensaria
coat
superparamagnet
iron
oxid
np
spion
pei
use
stimul
macrophag
found
ro
signal
involv
intriguingli
though
peicoat
spion
lp
induc
macrophag
activ
phenotyp
gene
upregul
gene
express
profil
differ
also
report
ovaload
plga
mp
peid
polyelectrolyt
multilay
induc
ro
attach
apc
posit
charg
outermost
layer
higher
molecular
weight
result
higher
ro
product
mani
nonpathogen
adjuv
includ
pei
toxic
tissu
circumst
ro
gener
although
ro
extens
interest
explor
peibas
vaccin
mechan
specif
role
relationship
immunityrel
molecul
still
merit
investig
danger
signal
elicit
pei
seem
main
caus
adjuv
effect
et
al
explor
gene
express
profil
peidna
bronchial
vaccin
found
bare
pei
upregul
express
gene
involv
cell
cycl
regul
oncogenesi
differenti
find
indic
cytotox
risk
involv
peibas
vaccin
hypothesi
went
along
previou
explan
aluminum
adjuv
immunoactiv
potenc
may
caus
physiolog
reaction
toward
sens
danger
signal
meanwhil
toxic
adjuv
investig
reveal
pei
revers
differenti
tumorassoci
macrophag
modul
activ
natur
killer
nk
kill
tumor
cell
similarli
cation
dextran
pei
also
found
repolar
myeloidderiv
suppressor
cell
mdsc
antitumor
phenotyp
knockout
mice
experi
prove
requir
signal
result
found
vitro
investig
lpei
produc
cytokin
wildtyp
mice
instead
litterm
therefor
lpei
consid
agonist
specul
lpei
structur
resembl
flagellin
et
al
found
peidna
vaccin
much
effect
nake
dna
vaccin
antitumor
trial
cocultiv
pei
bmdc
vitro
reveal
activ
express
import
nuclear
transloc
factor
import
nuclear
transcript
molecul
tlr
therefor
enhanc
type
imedi
cytotox
lymphocyt
activ
type
iimedi
respons
nk
might
relat
inflamm
apoptosi
induc
pei
wegmann
et
al
also
support
adjuvant
pei
promot
dc
traffick
dln
led
cytokin
secret
prove
immunoactiv
mechan
pei
relat
interferon
regulatori
factor
depend
signal
inflammasom
activ
shen
et
al
would
affect
cell
state
exhibit
variou
activ
impair
outcom
overal
effect
pei
recent
palumbo
et
al
construct
vitro
cocultur
system
demonstr
feasibl
transfect
peidna
vaccin
via
fibroblast
vaccin
surprisingli
result
crosspresent
antigen
dc
matur
compar
highand
lesstox
peidna
composit
correspond
dc
matur
state
well
mhc
irestrict
ova
present
result
highlight
polymerinduc
cytotox
probabl
benefit
immun
activ
mani
endogen
antigen
apoptot
necrot
cell
dsdna
heat
shock
protein
uric
acid
long
known
recruit
activ
immun
system
wegmann
et
al
report
prove
strong
depend
doublestrand
dna
dsdna
mediat
adjuv
effect
pei
free
cellular
dsdna
releas
apoptot
dead
cell
good
repres
damp
signal
investig
immun
respons
gener
pei
peibas
particl
stimul
immun
system
accompani
induct
variou
sort
cell
stress
immun
responserel
transcript
factor
yet
notori
difficult
elucid
mechan
clearli
evid
adjuv
effect
pei
peibas
particl
differ
research
gener
drawn
understand
figur
current
evid
support
danger
signal
damageassoci
molecular
pattern
theori
tlr
nlr
receptor
apc
recogn
danger
signal
peiassoci
cytotox
may
one
manifest
pattern
danger
signal
nontox
biomateri
also
profound
effect
immun
cell
experi
pei
also
found
nontox
vivo
still
possess
adjuvant
thu
mechan
may
exist
stimul
immun
addit
direct
toxic
pei
product
reflect
danger
damag
signal
figur
intrins
immunoactiv
properti
peibas
vaccin
peibas
particl
bind
prr
trigger
factor
elicit
seri
apc
matur
manifest
also
observ
elicit
ro
apc
gener
danger
signal
variou
rout
besid
peibas
particl
caus
bystand
cell
death
releas
seri
product
includ
uric
acid
releas
dna
other
materi
activ
inflammasom
pathway
gener
danger
signal
apc
matur
abbrevi
pei
polyethylenimin
prr
pattern
recognit
receptor
nuclear
interferon
regulatori
factor
apc
antigenpres
cell
ro
reactiv
oxygen
speci
mp
microparticl
np
nanoparticl
tlr
tolllik
receptor
mr
mannos
receptor
trif
tirdomaincontain
adapterinduc
myeloid
differenti
primari
respons
gene
mhc
major
histocompat
complex
il
interleukin
ifn
interferon
intern
journal
nanomedicin
submit
manuscript
wwwdovepresscom
polyethyleniminebas
micronanoparticl
adjuv
test
continu
ro
uric
acid
role
involv
clarifi
moreov
aboveexplain
factor
actual
independ
work
network
affect
mutual
exampl
activ
inflammasom
may
caus
uric
acid
form
necrosi
ro
besid
ro
induc
primari
gener
product
cell
stress
key
suppressor
rosinduc
apoptosi
intermedi
intermedi
bioactiv
cytokin
chemokin
ccl
famili
accessori
immun
cell
neutrophil
invari
nk
cell
also
involv
network
although
adjuv
capabl
increas
efficaci
clinic
vaccin
extens
studi
pace
develop
rel
slow
till
five
adjuv
licens
use
clinic
applic
us
food
drug
administr
european
medicin
agenc
includ
aluminum
virosom
among
even
aluminum
wide
use
adjuv
vaccin
almost
one
centuri
mani
advantag
good
safeti
profil
antigen
stabil
augment
hightit
antibodi
product
abil
elicit
cmi
furthermor
adjuv
licens
cancer
immunotherapi
indic
need
novel
adjuv
induc
robust
antitumor
cmi
therefor
desir
develop
new
immunostimul
adjuv
vaccin
formul
induc
robust
immun
respons
includ
humor
immun
cmi
interestingli
pei
confer
abil
induc
danger
signal
immun
cell
product
proinflammatori
cytokin
form
basi
adjuvant
given
limit
research
public
relat
effect
pei
immun
indepth
understand
immun
mechan
action
especi
relationship
cytotox
great
signific
moreov
biodistribut
biodegrad
peibas
vaccin
vivo
differ
size
shape
differ
administr
rout
differ
modif
strategi
still
need
investig
breakthrough
advanc
multidisciplinari
field
includ
chemistri
materi
scienc
immunolog
nanotechnolog
believ
peibas
vaccin
well
new
adjuv
improv
potenc
vaccin
precis
modul
appear
list
licens
adjuv
near
futur
